IkBNS regulates a subset of Toll-like receptor (TLR)-dependent genes including interleukin-6 (IL-6) by inhibiting nuclear factor-kB (NF-kB). IL-6 is an inflammatory biomarker for cardiovascular diseases. The aim of this study was to determine whether IkBNS changes arterial inflammation and intimal hyperplasia after vascular injury.
Introduction
Nuclear factor-kB (NF-kB) plays a central role in mediating cytokines, cell adhesion molecules, and other proteins of immunity in cell types resident to the plaque microenvironment, i.e. endothelial cells, smooth muscle cells (SMCs), and macrophages. Activation of NF-kB produces many inflammatory immune mediators including interleukin(IL)-6, tumour necrosis factor-a (TNF-a), and monocyte chemotactic protein-1 (MCP-1), and these mediators participate in the development of atherosclerotic lesions.
1 Activated NF-kB induces SMC proliferation and plays a central role in neointimal hyperplasia after vascular injury. 2 Because neointimal hyperplasia is a major contributor to restenosis, 3 understanding the mechanisms of neointimal hyperplasia after vascular injury provides many important implications for treatment of post-angioplasty restenosis. NF-kB activity is controlled by several mechanisms. IkBNS (also known as IkB-d, or Nfkbid: nuclear factor of k light polypeptide gene enhancer in B-cells inhibitor, delta) is a nuclear IkB protein which regulates NF-kB-dependent IL-6 production in mice. A recent report demonstrated that IkBNS disrupts docking between activated NF-kB and IL-6 promoter site, and inhibits IL-6 production after lipopolysaccharide (LPS) stimulation in murine macrophages in vitro. 4 In addition to IL-6, IkBNS also inhibits induction of Toll-like receptor (TLR)-dependent genes including IL-18 and IL-12p40. 5 IL-6 is an inflammatory biomarker for the progression of peripheral arterial disease, 6, 7 and IL-6 is a strong predictor of coronary artery disease and cardiovascular sudden death. 8, 9 These findings suggest that IL-6 is a key mediator in the development of arterial occlusive diseases. IkBNS might control NF-kB activity in endothelial cells, SMCs, and macrophages under inflammatory conditions. However, the role of IkBNS in neointimal formation after arterial injury remains unclear. We demonstrated here that IkBNS deficiency promotes neointimal hyperplasia by increasing TLR4 expression, NF-kB activity and IL-6 production by femoral artery injury with an external vascular cuff model.
Methods

Animals
The experimental protocol used in the study conforms to the Guide for the Care 
Details of IkBNS
2/2 mice were described in the previous report. 5 Mice were fed with normal chow diet.
Blood pressure measurement
Systolic blood pressure was measured by the tail-cuff method (MK-2000; Muromachi Kikai) without anaesthesia.
Femoral artery cuff injury
Mice were anaesthetized by intraperitoneal injection of pentobarbital (dose: 50 mg/kg bodyweight), and we added it if the mice moved to pain at operative time. We, thus, did not detect any movement of mice to pain, and their heart rate and respiration rate were also stable during the procedure. The right femoral artery was dissected from its surroundings and vascular injury was induced by placing a non-occlusive polyethylene cuff (length 2 mm, internal diameter 0.56 mm, Becton Dickinson) around the femoral artery. 10 Furthermore, to evaluate the role of IkBNS in TLR4 signalling pathway, we injected 20% Pluronic (F-127, Wako Pure Chemical Industries) gel containing LPS (1 mg/mL) between femoral artery and cuff. LPS was purchased from Sigma-Aldrich (Escherichia coli O55:B5, L2880).
Tissue preparation, image analysis, and quantification
Two weeks after cuff injury, mice were euthanized by pentobarbital injection and perfused with 0.9% saline followed by 4% paraformaldehyde. The femoral arteries were fixed in 10% formalin for 48 h, embedded in paraffin, and sectioned (5 mm thickness). We used equally spaced (200 mm interval) 10 cross sections to quantify neointimal lesion for each mouse. All samples were routinely stained with elastica van Gieson. Areas of intima and media were measured using NIH Image J 1.42 (National Institutes of Health, public domain software).
Immunohistochemistry
Primary antibodies are shown in the Supplementary material online, Methods. Sections were visualized using the avidin-biotin complex method with diaminobenzidine as the substrate.
Immunofluorescence staining for IkBNS
The femoral arteries were fixed in 4% paraformaldehyde overnight, embedded in OCT compound (Sakura Finetek 4583), and sectioned (10 mm thickness). 
Quantitative real-time PCR
Uninjured and injured arteries at 3, 7, and 14 days after cuff placement were pooled (two to four vessels for each sample). RNA was prepared from the pooled samples using TRI reagent (Sigma-Aldrich). Complementary DNA (cDNA) was synthesized using reverse transcriptase from 200 ng total RNA according to the manufacturer's protocol (High Capacity cDNA Reverse Transcription Kit; Applied Biosystems). PCR primers are shown in the Supplementary material online, Table S1 . We performed real-time PCR as described before. 11 
Cell proliferation and migration assay in vitro
Mouse vascular SMCs were isolated from the aorta, as described previously. 12 Cell proliferation was analysed by the BrdU In-Situ Detection Kit (55080, BD Pharmingen) according to manufacturer's protocol. Cell migration was analysed by the scratch-wound healing assay. 13 Details of in vitro studies are shown in the Supplementary material online, Methods.
Analysis for serum IL-6 levels and cholesterol profiles after cuff injury
After fasting for 7 h, blood samples were collected from IkBNS 2/2 and IkBNS +/+ mice 2 weeks after cuff injury. Serum cytokine and chemokine levels were analysed using the BioPlex kits (BioRad) according to the manufacturer's protocol. Total cholesterol, high-density lipoprotein (HDL) cholesterol and triglyceride were measured by enzymatic assays as described previously. To evaluate the effect of IL-6 on neointimal formation, IkBNS 2/2 mice were injected intraperitoneally with 10 mg/kg of rat anti-mouse IL-6 receptor antibody (MR16-1) or control IgG three times per week after cuff injury, as described. 15 MR16-1 was gifted from Chugai Pharmaceutical and control IgG was purchased from Jackson ImmunoResearch (012-000-003).
Statistical analysis
Results are shown as the mean + SEM. The two groups were compared using Student's t-test. Two-way ANOVA was used to compare time course expression of mRNA levels between two groups after cuff injury. P , 0.05 was regarded as a significant difference.
Results
Phenotypic characteristics
There was no significant difference in baseline phenotypic characteristics between IkBNS Figure 1 ).
Neointimal formation after cuff injury
To examine post-injury cell proliferation in the intima of both groups, we performed a-smooth muscle cell actin (a-SMA), proliferating cell nuclear antigen (PCNA), and phospho-NF-kB p65 (pNF-kB) staining in injured arteries of both groups. Figure 2A 
Macrophage recruitment and TLR4 expression after cuff injury
To check the recruitment of inflammatory cells, we performed immunohistochemistry for macrophages (MAC-3), neutrophils (Ly-6G), and T cells (CD3). Macrophages were main inflammatory cells recruited in the adventitia after cuff injury ( Figure 3A ), but neutrophils and T cells were rare (see Supplementary material online, Figure S1 ). However, we observed no significant difference in the number of macrophage [35.5 + 6.5 (n ¼ 4) vs. 39.5 + 6.9 (n ¼ 4); P ¼ NS] between two groups ( Figure 3B ).
To evaluate the TLR expression after injury, we performed immunohistochemistry for TLR2 and TLR4. TLR2 expression was weak in both mice within 7 days after cuff injury (data not shown). In contrast, we observed strong TLR4 expression in the intima of IkBNS 2/2 mice at 7 days post-injury ( Figure 3C ). Real-time PCR analysis also revealed that mRNA expression levels of TLR4 in IkBNS 2/2 mice were 2.5-fold higher (P ¼ 0.001) than those in IkBNS +/+ mice at 3 days after cuff injury ( Figure 3D ). To check the role of IkBNS in TLR4 signalling pathway, we filled the space between femoral artery and cuff with Pluronic gel containing LPS (1 mg/mL 
Time course of IL-6 and IkBNS expression after cuff injury
We analysed IL-6 and IkBNS expression after cuff injury. IL-6 protein expression was stronger in the intima and the media of IkBNS
mice compared with those of IkBNS +/+ mice at 7 and 14 days after cuff injury ( Figure 4A ). To quantify mRNA expression levels of IL-6, we performed real-time PCR analysis using uninjured and injured arteries from both groups. Expression levels of IL-6 mRNA in IkBNS 2/2 mice were significantly higher compared with IkBNS +/+ mice from 3 to 14 days after cuff injury (P ¼ 0.044 by two-way ANOVA). In particular, at 3 days post-injury, IL-6 mRNA levels in IkBNS 2/2 mice were 1.8-fold higher (P ¼ 0.002) compared
with IkBNS +/+ mice ( Figure 4B) . We also checked time course of IkBNS expression after cuff injury. We detected IkBNS protein expression in the adventitia at 7 days, and in the media at 14 days after injury in IkBNS +/+ mice ( Figure 4C ). IkBNS mRNA expression was detected in IkBNS +/+ mice from 3 to 14 days after injury ( Figure 4D ).
Cell proliferation and migration assay in vitro
To assess the effect of IkBNS deficiency on cell proliferation, we performed BrdU incorporation assay. We observed PDGF-BB (20 ng/ mL)-induced BrdU incorporation in SMCs from both groups, but there was no significant difference in the percentage of BrdU positive cells to total cells between groups [10.0 + 3.6% (n ¼ 4) vs. 8.8 + 2.8% (n ¼ 4); P ¼ NS]. In contrast, we did not detect BrdU incorporation in SMCs from both mice after IL-6 (20 ng/mL) stimulation (see Supplementary material online, Figure S2 ). To evaluate the effect of IL-6 on cell migration, we performed the scratch-wound healing assay in cultured SMCs. (20 ng/mL) stimulation ( Figure 5A and B) . Furthermore, pretreatment with anti-mouse IL-6 receptor antibody (MR16-1, 100 mg/mL) completely inhibited SMC migration after IL-6 stimulation in both groups ( Figure 5C and D) . T. Niida et al.
Serum IL-6 levels and cholesterol profiles after cuff injury
To check the serum IL-6 levels and cholesterol profiles after vascular injury, we analysed blood samples from IkBNS 2/2 and IkBNS +/+ mice 2 weeks after cuff injury (see Supplementary material online, Table S2 ). (Figure 6A and B) .
Immunohistochemistry showed that MR16-1 did not inhibit IL-6 The results of the cuff groups are same data shown in Figure 1B .
IkBNS inhibits neointimal formation protein expression at 14 days after treatment in injured arteries of IkBNS 2/2 mice ( Figure 6C ). Real-time PCR analysis also revealed that mRNA expression levels of IL-6 did not differ between groups at 3 days after treatment ( Figure 6D) . However, the percentage of phosphorylated signal transducer and activator of transcription 3 (pStat3) positive cells in the intima of the MR16-1 group was significantly lower than that of the control group [31.9 + 4.6% (n ¼ 6) vs. 64.1 + 4.9% (n ¼ 6); P ¼ 0.001] at 7 days after treatment ( Figure 6E and F ).
Discussion
This study is the first to demonstrate the role of IkBNS in injured arteries in vivo and in vitro. IkBNS deficiency caused neointimal formation by increasing TLR4 expression, NF-kB activity and SMC proliferation in the intima of injured arteries. Expression levels of IL-6 mRNA were significantly higher than those of IkBNS +/+ mice. Vascular SMCs from IkBNS 2/2 mice showed significant increase in cell migration compared with those from IkBNS +/+ mice after IL-6 stimulation in vitro.
Furthermore, neointimal formation was inhibited by anti-mouse IL-6 receptor antibody in IkBNS 2/2 mice. These results suggest that
IkBNS plays an important role in arterial inflammation and intimal hyperplasia by inhibiting IL-6 production after injury.
Our histological findings revealed that deficiency of IkBNS promotes NF-kB activity and SMC proliferation in the intima of injured arteries. Constitutive NF-kB activation is essential for the proliferation of vascular SMCs. 16 Breuss et al. 17 showed post-angioplasty lumen narrowing by enhancing NF-kB activity in rabbit iliac artery. Furthermore, two research groups demonstrated that NF-kB decoy inhibits restenosis after coronary stenting in rabbit and human. 18, 19 These results support that NF-kB plays an important role in the progression of neointimal hyperplasia after angioplasty. NF-kB activation also associates with the development of atherosclerosis. 20 Activated NF-kB is detected in endothelial cells, SMCs, and macrophages of atherosclerotic lesions. 1 Atherosclerotic lesion development includes proliferation of intimal SMCs, 21 therefore examination of neointimal formation in IkBNS 2/2 mice might provide essential information regarding atherosclerosis progression and restenosis following vascular injury.
We detected many macrophages in the adventitia of injured arteries. Macrophages might induce adventitial inflammation, and may participate in neointimal formation after cuff injury. But we observed no significant difference in the number of macrophage in the adventitia between IkBNS +/+ and IkBNS 2/2 mice. Although deficiency of IkBNS may not affect macrophage recruitment, IkBNS-deficient macrophages might modify those function, including prolonged NF-kB activation and IL-6 expression. 5 To check the effect of IkBNS on fibrotic remodelling, we performed Picrosirius red staining in representative samples from both mice (see Supplementary material online, Figure S3 ). We observed there was no collagen in the neointima of both mice, suggesting deficiency of IkBNS may not affect collagen reconstruction within 2 weeks after injury. Activated NF-kB induces various inflammatory cytokines and chemokines such as IL-6, TNF-a and MCP-1. 22, 23 We focused on the IL-6 regulation system in vascular injury. Wang et al. 24 demonstrated that IL-6 promotes rat SMC migration in a dose-dependent manner in vitro. Moreover, the sirolimus-eluting stent reduces neointimal formation and IL-6 production in injured arteries of a porcine coronary model. 25 These results support the importance of IL-6 in neointimal formation after vascular injury. In our study, IL-6 mRNA expression levels were significantly higher in injured arteries of IkBNS Figure S4 ). Previous report showed that IL-18 plays a critical role in neointima formation after vascular injury via NF-kB activation. 30 These findings indicate that TLR4 signalling also participates in the development of intimal hyperplasia in IkBNS 2/2 mice after vascular injury with or without LPS.
To block the effect of IL-6 on neointimal formation, we treated IkBNS 2/2 mice by anti-mouse IL-6 receptor antibody (MR16-1).
The effect of MR16-1 has been demonstrated in the murine arthritis model, 31, 32 and safety and efficacy of humanized anti IL-6 receptor antibody (tocilizumab) has been established in several clinical trials in rheumatic arthritis patients. 33 Earlier reports show that IL-6
induces phosphorylation of Stat3 in vascular SMC and causes neointimal hyperplasia after balloon injury in rats. 24, 34 We analysed pStat3
positive cells to evaluate the inhibitory effect of MR16-1 in IL-6 signalling pathway. MR16-1 inhibited Stat3 activation and neointimal hyperplasia after cuff injury in IkBNS 2/2 mice, suggesting IL-6 is a major contributor to neointimal hyperplasia in IkBNS 2/2 mice, and inhibition of IL-6 might be a new method to prevent neointimal formation after vascular injury. IL-6 is known as a representative inflammatory biomarker because this cytokine induces acute phase protein such as C-reactive protein and fibrinogen. 35 The serum IL-6 level is strongly associated with severity of ankle-brachial index in peripheral arterial disease patients. 6, 7 Furthermore, IL-6 is associated with restenosis after coronary stenting 36 and a strong predictor of cardiovascular death. 8, 9 In our study, the serum IL-6 level was significantly higher in IkBNS 2/2 mice compared with IkBNS +/+ mice, although there was no significant difference in hepatic IL-6 mRNA expression levels between two groups [1.0 + 0.1 (n ¼ 6) vs. 1.0 + 0.1 (n ¼ 6); P ¼ NS] at 2 weeks after cuff injury. Furthermore, we observed no significant difference in heart weight to the body weight ratio [6.7 + 0.3 mg/g (n ¼ 6) vs. 6.9 + 0.3 mg/g (n ¼ 6); P ¼ NS) and left ventricular wall thickness (1.3 + 0.1 vs. 1.3 + 0.1 mm; P ¼ NS) between groups at 2 weeks after injury. These findings suggest that the high serum IL-6 level in IkBNS 2/2 mice might be induced by local injury and may not affect cardiac hypertrophy within 2 weeks after injury. With regard to cholesterol metabolism, we observed lower HDL cholesterol in IkBNS 2/2 mice after vascular injury. A previous study demonstrated that recombinant IL-6 injection with high-fat diet accelerates atherosclerosis in wild-type mice. 37 Moreover, high serum levels of IL-6
are independently associated with low HDL cholesterol levels in elderly people. 38 Taken together, there is a possibility that IkBNS 2/2 mice exacerbate atherosclerosis by cholesterol-rich diet.
But further investigation is needed to evaluate the role of IkBNS in hyperlipidaemia because we used normal chow diet in this study. NF-kB and its regulator IkB proteins participate importantly in the regulation of host immune responses. In this study, we elucidated the role of IL-6 that participates in neointimal formation after vascular injury in IkBNS 2/2 mice. It has been also reported that IL-6 expression is detected in human atherosclerotic lesions. 39 Therefore, further investigation for IkBNS in human endothelial cells, SMCs, and macrophages may aid development of new therapies for cardiovascular diseases. In conclusion, IkBNS down-regulates TLR4 expression and NF-kB activity, and inhibits induction of TLR4-dependent genes including IL-6 after cuff injury. IkBNS might suppress intimal hyperplasia caused by vascular inflammation such as atherosclerosis, and restenosis after angioplasty.
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